Category
All
New Technology
Service & Software
Internet & Communication
Electronics & Semiconductor
Pharma & Healthcare
Other
Energy & Power
Agriculture
Consumer Goods
Machinery & Equipment
Food & Beverages
Medical Care
Automobile & Transportation
Packaging
Chemical & Material
Medical Devices & Consumables
Category
All
Total: 7 records, 1 pages
Search For: Somatostatin Analogs
Global Somatostatin Analogs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
26 Jan 2024
Pharma & Healthcare
According to our (Global Info Research) latest study, the global Somatostatin Analogs market size was valued at USD 4630.6 million in 2023 and is forecast to a readjusted size of USD 6422.9 million by 2030 with a CAGR of 4.8% during review period.
USD3480.00
Add To Cart
Global Somatostatin and Somatostatin Analogs Supply, Demand and Key Producers, 2024-2030
18 Feb 2024
Pharma & Healthcare
Somatostatin and Somatostatin Analogs
The global Somatostatin and Somatostatin Analogs market size is expected to reach $ 184.7 million by 2030, rising at a market growth of -5.4% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
Global Somatostatin and Somatostatin Analogs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
09 Jan 2024
Pharma & Healthcare
Somatostatin and Somatostatin Analogs
According to our (Global Info Research) latest study, the global Somatostatin and Somatostatin Analogs market size was valued at USD 271.6 million in 2023 and is forecast to a readjusted size of USD 184.7 million by 2030 with a CAGR of -5.4% during review period.
USD3480.00
Add To Cart
Global Somatostatin Analogs Supply, Demand and Key Producers, 2023-2029
06 Mar 2023
Pharma & Healthcare
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
USD4480.00
Add To Cart
Global Somatostatin Analogs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
03 Jan 2023
Pharma & Healthcare
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
USD3480.00
Add To Cart
Global Somatostatin and Somatostatin Analogs Supply, Demand and Key Producers, 2023-2029
25 Feb 2023
Pharma & Healthcare
Somatostatin and Somatostatin Analogs
The global Somatostatin and Somatostatin Analogs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Global Somatostatin and Somatostatin Analogs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
09 Jan 2023
Pharma & Healthcare
Somatostatin and Somatostatin Analogs
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
USD3480.00
Add To Cart
Popular Product Keywords
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
Search For: Somatostatin Analogs
Total: 7 records, 1 pages
According to our (Global Info Research) latest study, the global Somatostatin Analogs market size was valued at USD 4630.6 million in 2023 and is forecast to a readjusted size of USD 6422.9 million by 2030 with a CAGR of 4.8% during review period.
USD3480.00
Add To Cart
The global Somatostatin and Somatostatin Analogs market size is expected to reach $ 184.7 million by 2030, rising at a market growth of -5.4% CAGR during the forecast period (2024-2030).
USD4480.00
Add To Cart
According to our (Global Info Research) latest study, the global Somatostatin and Somatostatin Analogs market size was valued at USD 271.6 million in 2023 and is forecast to a readjusted size of USD 184.7 million by 2030 with a CAGR of -5.4% during review period.
USD3480.00
Add To Cart
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
USD4480.00
Add To Cart
Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.
USD3480.00
Add To Cart
The global Somatostatin and Somatostatin Analogs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
USD4480.00
Add To Cart
Somatostatin is one kind of hormone. It is widely distributed throughout the body, especially in the hypothalamus and pancreas. It also acts as an important regulator of endocrine and nervous system function by inhibiting the secretion of several other hormones such as growth hormone, insulin, and gastrin.
USD3480.00
Add To Cart
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
-
Insight into the industry market information
-
Analyze market development needs
-
Prospects for future development
-
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>